Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter ITGA4 (Natalizumab Biosimilar) Antikörper

Reaktivität: Human FACS, BR Wirt: Human Monoclonal unconjugated Recombinant Antibody
Produktnummer ABIN5668196
  • Target Alle ITGA4 (Natalizumab Biosimilar) Produkte
    ITGA4 (Natalizumab Biosimilar)
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    Human
    Wirt
    • 1
    • 1
    • 1
    • 1
    Human
    Klonalität
    • 2
    • 2
    Monoklonal
    Konjugat
    • 4
    Dieser ITGA4 (Natalizumab Biosimilar) Antikörper ist unkonjugiert
    Applikation
    Flow Cytometry (FACS), Blocking Reagent (BR)
    Spezifität
    This antibody binds to the alpha 4 binds subunit of α4β1 (also known as very late antigen 4 [VLA-4] or CD49d-CD29) and α4β7 integrin
    Produktmerkmale

    OriginalSpeciesName: Human

    OriginalFormat: IgG4

    Aufreinigung
    Purified antibody.
    Reinheit
    > 98 % as determined by SDS-PAGE
    Endotoxin-Niveau
    Endotoxin is < 1.0 EU/mg as determined by the LAL method
    Immunogen
    The RAMOS cell line, a non-EBV releasing cell line, injected into mice.
    Isotyp
    IgG4 kappa
  • Applikationshinweise
    This antibody binds to human integrin alpha 4 and has been used to treat Multiple Sclerosis and Crohn's Disease.
    Kommentare

    NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS with 0.02 % Proclin 300.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Cegarra, Cameron, Chaves, Dabdoubi, Do, Genêt, Roudières, Shi, Tchepikoff, Lesuisse: "An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family." in: PloS one, Vol. 17, Issue 9, pp. e0274667, (2022) (PubMed).

  • Target
    ITGA4 (Natalizumab Biosimilar)
    Abstract
    ITGA4 (Natalizumab Biosimilar) Produkte
    Synonyme
    CD49D antikoerper, IA4 antikoerper, integrin subunit alpha 4 antikoerper, ITGA4 antikoerper
    Hintergrund
    CD49D, alpha 4 subunit of VLA-4 receptor, ITGA4, Integrin alpha-IV
    UniProt
    P13612
Sie sind hier:
Kundenservice